Suscribete

Pancreatic Cancer Immunotherapy Clinical Trial Launches at UPENN

A new clinical trial for pancreatic cancer immunotherapy funded by the Cancer Research Institute and the Lustgarten...

Community-wide Consensus Process Generates a Framework for Reporting of T-cell Experiments in Clinic

The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of the Cancer Research Institute...

CRI and SU2C Announce $6 Million Dream Team Grant

The Cancer Research Institute and Stand Up To Cancer, in partnership with the American Association for Cancer...

Antibodies to Intracellular Cancer Antigens Combined with Chemotherapy Enhance Anti-cancer Immunity

Pre-clinical study by scientists funded by Cancer Research Institute and Ludwig Institute for Cancer Research confirmed that...

Lloyd J. Old, MD, Father of Modern Tumor Immunology, Dies at 78 of Prostate Cancer

CRI announced today its founding scientific and medical director Lloyd J. Old, MD, regarded as the “Father...

Critical Value Demonstrated for Immune Assay Harmonization

The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of CRI published a joint...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.